Financhill
Buy
55

IOSP Quote, Financials, Valuation and Earnings

Last price:
$111.29
Seasonality move :
5.11%
Day range:
$109.07 - $111.39
52-week range:
$103.97 - $133.71
Dividend yield:
1.39%
P/E ratio:
19.43x
P/S ratio:
1.49x
P/B ratio:
2.23x
Volume:
50.4K
Avg. volume:
132.3K
1-year change:
-10.15%
Market cap:
$2.8B
Revenue:
$1.9B
EPS (TTM):
$5.73

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IOSP
Innospec
$442.1M $1.35 -9.56% -9.49% --
ALTO
Alto Ingredients
$267.6M $0.05 6.73% -57.69% --
BCPC
Balchem
$241.9M $1.12 4.92% 34.76% --
FRD
Friedman Industries
-- -- -- -- --
PZG
Paramount Gold Nevada
-- -$0.03 -- -- --
XPL
Solitario Resources
-- -$0.02 -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IOSP
Innospec
$111.32 -- $2.8B 19.43x $0.79 1.39% 1.49x
ALTO
Alto Ingredients
$1.63 -- $124.9M -- $0.00 0% 0.12x
BCPC
Balchem
$167.17 -- $5.4B 44.94x $0.79 0.47% 5.79x
FRD
Friedman Industries
$15.85 -- $110.4M 13.90x $0.04 0.88% 0.24x
PZG
Paramount Gold Nevada
$0.33 -- $22.1M -- $0.00 0% --
XPL
Solitario Resources
$0.60 -- $48.6M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IOSP
Innospec
-- 1.940 -- 1.69x
ALTO
Alto Ingredients
24% 0.183 67.56% 1.90x
BCPC
Balchem
16.17% 2.051 3.97% 1.77x
FRD
Friedman Industries
21.78% 0.899 32.37% 1.16x
PZG
Paramount Gold Nevada
-- 0.136 -- --
XPL
Solitario Resources
-- -1.475 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IOSP
Innospec
$124.1M $47.9M 12.17% 12.17% 10.8% $61.7M
ALTO
Alto Ingredients
$6M -$1.6M -10.1% -13.16% -0.23% $18.1M
BCPC
Balchem
$85.4M $48M 8.77% 11.16% 19.99% $42.2M
FRD
Friedman Industries
$10.1M -$2K 4.68% 6.32% -0.03% $8.9M
PZG
Paramount Gold Nevada
-$166.6K -$1.4M -- -- -- -$1.2M
XPL
Solitario Resources
-$8K -$2.5M -- -- -- -$1.8M

Innospec vs. Competitors

  • Which has Higher Returns IOSP or ALTO?

    Alto Ingredients has a net margin of 7.53% compared to Innospec's net margin of -0.97%. Innospec's return on equity of 12.17% beat Alto Ingredients's return on equity of -13.16%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    ALTO
    Alto Ingredients
    2.37% -$0.04 $347.3M
  • What do Analysts Say About IOSP or ALTO?

    Innospec has a consensus price target of --, signalling upside risk potential of 17.68%. On the other hand Alto Ingredients has an analysts' consensus of -- which suggests that it could grow by 176.07%. Given that Alto Ingredients has higher upside potential than Innospec, analysts believe Alto Ingredients is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    ALTO
    Alto Ingredients
    0 0 0
  • Is IOSP or ALTO More Risky?

    Innospec has a beta of 1.086, which suggesting that the stock is 8.649% more volatile than S&P 500. In comparison Alto Ingredients has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.251%.

  • Which is a Better Dividend Stock IOSP or ALTO?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.39%. Alto Ingredients offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 25.23% of its earnings as a dividend. Alto Ingredients pays out -4.52% of its earnings as a dividend. Innospec's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or ALTO?

    Innospec quarterly revenues are $443.4M, which are larger than Alto Ingredients quarterly revenues of $251.8M. Innospec's net income of $33.4M is higher than Alto Ingredients's net income of -$2.4M. Notably, Innospec's price-to-earnings ratio is 19.43x while Alto Ingredients's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.49x versus 0.12x for Alto Ingredients. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.49x 19.43x $443.4M $33.4M
    ALTO
    Alto Ingredients
    0.12x -- $251.8M -$2.4M
  • Which has Higher Returns IOSP or BCPC?

    Balchem has a net margin of 7.53% compared to Innospec's net margin of 14.1%. Innospec's return on equity of 12.17% beat Balchem's return on equity of 11.16%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    BCPC
    Balchem
    35.58% $1.03 $1.4B
  • What do Analysts Say About IOSP or BCPC?

    Innospec has a consensus price target of --, signalling upside risk potential of 17.68%. On the other hand Balchem has an analysts' consensus of -- which suggests that it could grow by 13.86%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    BCPC
    Balchem
    0 0 0
  • Is IOSP or BCPC More Risky?

    Innospec has a beta of 1.086, which suggesting that the stock is 8.649% more volatile than S&P 500. In comparison Balchem has a beta of 0.668, suggesting its less volatile than the S&P 500 by 33.165%.

  • Which is a Better Dividend Stock IOSP or BCPC?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.39%. Balchem offers a yield of 0.47% to investors and pays a quarterly dividend of $0.79 per share. Innospec pays 25.23% of its earnings as a dividend. Balchem pays out 21.07% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or BCPC?

    Innospec quarterly revenues are $443.4M, which are larger than Balchem quarterly revenues of $239.9M. Innospec's net income of $33.4M is lower than Balchem's net income of $33.8M. Notably, Innospec's price-to-earnings ratio is 19.43x while Balchem's PE ratio is 44.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.49x versus 5.79x for Balchem. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.49x 19.43x $443.4M $33.4M
    BCPC
    Balchem
    5.79x 44.94x $239.9M $33.8M
  • Which has Higher Returns IOSP or FRD?

    Friedman Industries has a net margin of 7.53% compared to Innospec's net margin of -0.63%. Innospec's return on equity of 12.17% beat Friedman Industries's return on equity of 6.32%.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    FRD
    Friedman Industries
    9.5% -$0.10 $164.6M
  • What do Analysts Say About IOSP or FRD?

    Innospec has a consensus price target of --, signalling upside risk potential of 17.68%. On the other hand Friedman Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that Innospec has higher upside potential than Friedman Industries, analysts believe Innospec is more attractive than Friedman Industries.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    FRD
    Friedman Industries
    0 0 0
  • Is IOSP or FRD More Risky?

    Innospec has a beta of 1.086, which suggesting that the stock is 8.649% more volatile than S&P 500. In comparison Friedman Industries has a beta of 1.410, suggesting its more volatile than the S&P 500 by 41.002%.

  • Which is a Better Dividend Stock IOSP or FRD?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.39%. Friedman Industries offers a yield of 0.88% to investors and pays a quarterly dividend of $0.04 per share. Innospec pays 25.23% of its earnings as a dividend. Friedman Industries pays out 3.35% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or FRD?

    Innospec quarterly revenues are $443.4M, which are larger than Friedman Industries quarterly revenues of $106.8M. Innospec's net income of $33.4M is higher than Friedman Industries's net income of -$675K. Notably, Innospec's price-to-earnings ratio is 19.43x while Friedman Industries's PE ratio is 13.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.49x versus 0.24x for Friedman Industries. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.49x 19.43x $443.4M $33.4M
    FRD
    Friedman Industries
    0.24x 13.90x $106.8M -$675K
  • Which has Higher Returns IOSP or PZG?

    Paramount Gold Nevada has a net margin of 7.53% compared to Innospec's net margin of --. Innospec's return on equity of 12.17% beat Paramount Gold Nevada's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    PZG
    Paramount Gold Nevada
    -- -$0.02 --
  • What do Analysts Say About IOSP or PZG?

    Innospec has a consensus price target of --, signalling upside risk potential of 17.68%. On the other hand Paramount Gold Nevada has an analysts' consensus of -- which suggests that it could grow by 259.6%. Given that Paramount Gold Nevada has higher upside potential than Innospec, analysts believe Paramount Gold Nevada is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    PZG
    Paramount Gold Nevada
    0 0 0
  • Is IOSP or PZG More Risky?

    Innospec has a beta of 1.086, which suggesting that the stock is 8.649% more volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.854, suggesting its more volatile than the S&P 500 by 85.435%.

  • Which is a Better Dividend Stock IOSP or PZG?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.39%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 25.23% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend. Innospec's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or PZG?

    Innospec quarterly revenues are $443.4M, which are larger than Paramount Gold Nevada quarterly revenues of --. Innospec's net income of $33.4M is higher than Paramount Gold Nevada's net income of -$1.6M. Notably, Innospec's price-to-earnings ratio is 19.43x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.49x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.49x 19.43x $443.4M $33.4M
    PZG
    Paramount Gold Nevada
    -- -- -- -$1.6M
  • Which has Higher Returns IOSP or XPL?

    Solitario Resources has a net margin of 7.53% compared to Innospec's net margin of --. Innospec's return on equity of 12.17% beat Solitario Resources's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IOSP
    Innospec
    27.99% $1.33 $1.2B
    XPL
    Solitario Resources
    -- -$0.03 --
  • What do Analysts Say About IOSP or XPL?

    Innospec has a consensus price target of --, signalling upside risk potential of 17.68%. On the other hand Solitario Resources has an analysts' consensus of -- which suggests that it could grow by 151.21%. Given that Solitario Resources has higher upside potential than Innospec, analysts believe Solitario Resources is more attractive than Innospec.

    Company Buy Ratings Hold Ratings Sell Ratings
    IOSP
    Innospec
    0 1 0
    XPL
    Solitario Resources
    0 0 0
  • Is IOSP or XPL More Risky?

    Innospec has a beta of 1.086, which suggesting that the stock is 8.649% more volatile than S&P 500. In comparison Solitario Resources has a beta of 0.895, suggesting its less volatile than the S&P 500 by 10.55%.

  • Which is a Better Dividend Stock IOSP or XPL?

    Innospec has a quarterly dividend of $0.79 per share corresponding to a yield of 1.39%. Solitario Resources offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innospec pays 25.23% of its earnings as a dividend. Solitario Resources pays out -- of its earnings as a dividend. Innospec's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios IOSP or XPL?

    Innospec quarterly revenues are $443.4M, which are larger than Solitario Resources quarterly revenues of --. Innospec's net income of $33.4M is higher than Solitario Resources's net income of -$2.3M. Notably, Innospec's price-to-earnings ratio is 19.43x while Solitario Resources's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innospec is 1.49x versus -- for Solitario Resources. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IOSP
    Innospec
    1.49x 19.43x $443.4M $33.4M
    XPL
    Solitario Resources
    -- -- -- -$2.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 25

Power Solutions International [PSIX] is up 27.42% over the past day.

Buy
65
TSLL alert for Dec 25

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
75
SMLR alert for Dec 25

Semler Scientific [SMLR] is up 15.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock